Compare Johnson & Johnson (JNJ) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Wayfair Inc — how do they compare? Johnson & Johnson trades at $260.77 (market cap $626.09B), while Wayfair Inc trades at $103.75 (market cap $14.14B). The key difference: Johnson & Johnson is far larger — about 44.3× Wayfair Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| JNJ | W | |
|---|---|---|
Market Cap | $626.09B | $14.14B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $119.05 |
52-Week Low | $172.78 | $57.40 |
Enterprise Value | $654.37B | $16.47B |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
Wayfair (W) trades at $103.59, up 0.25% with bullish technical signals including a golden cross pattern. The company reported strong Q2 2026 results with EPS of $0.95 beating estimates and 7.5% revenue growth. Despite negative net margins, operating cash flow improved to $534 million in 2025. Analyst consensus leans bullish with 52% buy ratings and a $122 price target representing 18% upside potential.
The outlook remains positive driven by U.S. market share gains and margin expansion guidance, though risks include persistent losses and high debt levels. Technical support at $102 provides near-term protection while resistance at $105-108 marks the next challenge. The stock's momentum appears sustainable if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
